Frontiers In Cardiovascular Medicine SCIE

國際簡稱：FRONT CARDIOVASC MED 參考譯名：心血管醫(yī)學(xué)前沿

主要研究方向：Medicine-Cardiology and Cardiovascular Medicine 非預(yù)警期刊審稿周期： 14 Weeks

《心血管醫(yī)學(xué)前沿》(Frontiers In Cardiovascular Medicine)是一本由Frontiers Media S.A.出版的以Medicine-Cardiology and Cardiovascular Medicine為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
2199 年發(fā)文量
2.8 IF影響因子
未開放 是否OA
2014 創(chuàng)刊年份
1 issue/year 出版周期
English 出版語言

Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?

At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.

[ 查看全部 ]

投稿咨詢加急咨詢

Frontiers In Cardiovascular Medicine期刊信息

ISSN：2297-055X
出版語言：English
是否OA：未開放
E-ISSN：2297-055X
出版地區(qū)：SWITZERLAND
是否預(yù)警：否
出版商：Frontiers Media S.A.
出版周期：1 issue/year
創(chuàng)刊時間：2014
開源占比：0.993
Gold OA文章占比：99.58%
OA被引用占比：1
出版國人文章占比：0.08
出版撤稿占比：0
研究類文章占比：75.99%

Frontiers In Cardiovascular Medicine CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

3.8

0.863

0.742

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Cardiology and Cardiovascular Medicine	Q2	161 / 387	58%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Frontiers In Cardiovascular Medicine中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

Frontiers In Cardiovascular Medicine JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	79 / 220	64.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	80 / 220	63.86%

Frontiers In Cardiovascular Medicine歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Frontiers In Cardiovascular Medicine中國學(xué)者發(fā)文選摘

1、The incidence and risk factors of perioperative cardiac complications in noncardiac major surgery in high-altitude areas: A prospective trial in Tibet autonomous region, China
Author: Zhu, Qianmei; Duan, Hanyu; Liu, Zijia; Li, Yi; Zhang, Yuelun; Labaciren, Labaciren; Shen, Le; Huang, Yuguang

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1158711
2、Wall shear stress and its role in atherosclerosis
Author: Zhou, Manli; Yu, Yunfeng; Chen, Ruiyi; Liu, Xingci; Hu, Yilei; Ma, Zhiyan; Gao, Lingwei; Jian, Weixiong; Wang, Liping

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1083547
3、Impact of the degree of worsening renal function and B-type natriuretic peptide on the prognosis of patients with acute heart failure
Author: Zhao, Dongfang; Gu, Lijie; Wei, Wenqian; Peng, Dan; Yang, Man; Yuan, Weijie; Rong, Shu

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1103813
4、Diltiazem is a useful and effective medication for reversal of coronary artery spasm-induced complete atrioventricular block: A case report
Author: Zhang, Jin; Liu, Li; Liu, Chengwei; Han, Min; Xu, Chengyi; Qiu, Rujie

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1134658
5、Longitudinal changes in blood pressure and fasting plasma glucose among 5,398 primary care patients with concomitant hypertension and diabetes: An observational study and implications for community-based cardiovascular prevention
Author: Yu, Xiao; Li, Yu Ting; Cheng, Hui; Zhu, Sufen; Hu, Xiu-Jing; Wang, Jia Ji; Mohammed, Bedru H.; Xie, Yao Jie; Hernandez, Jose; Wu, Hua-Feng; Wang, Harry H. X.

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1120543
6、Efficacy of left subclavian artery revascularization strategies during thoracic endovascular aortic repair in patients with type B dissection: A single-center experience of 105 patients
Author: Wu, Xiangyang; Li, Yongnan; Zhao, Yinglu; Zhu, Yilin; Wang, Shixiong; Ma, Qi; Liu, Debin; Gao, Bingren; Wei, Shilin; Wang, Weifan

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1084851
7、Clinical efficacy and safety of Cox-maze IV procedure for atrial fibrillation in patients with aortic valve calcification
Author: Guo, Ruikang; Fan, Chengming; Sun, Zhishan; Zhang, Hao; Sun, Yaqin; Song, Long; Jiang, Zenan; Liu, Liming

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1092068
8、Machine learning-based in-hospital mortality risk prediction tool for intensive care unit patients with heart failure
Author: Chen, Zijun; Li, Tingming; Guo, Sheng; Zeng, Deli; Wang, Kai

Journal: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2023; Vol. 10, Issue , pp. -. DOI: 10.3389/fcvm.2023.1119699